RecruitingPhase 4NCT06903975

BoTox Into the Sternocleidomastoid Muscles (SCM)

The Effect of Injection of prabotulinumtoxinA-xvfs (Jeuveau) Into the Bilateral Sternocleidomastoid Muscles on Neck Circumference and Aesthetics


Sponsor

Boston Medical Center

Enrollment

30 participants

Start Date

May 14, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Botulinum toxin injections have been used both in the face and neck for many years. However, injection into the sternocleidomastoid muscle (SCM) has only been done to treat neck spasms. In this study botulinum toxin will be injected into the SCM to determine if this will result in a temporary slimming effect on the neck and produce a more feminine, youthful neck contour.


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Inclusion Criteria1

  • Age eligible individual seeking a more feminine neck appearance

Exclusion Criteria6

  • Prior neuromodulator injections in the sternocleidomastoid muscles (SCM) within the past year
  • Current anticoagulant use
  • Body mass index (BMI) >30
  • Anticipation of significant weight gain or loss during the study period (e.g. patients taking or planning to take within the study period a semaglutide medication.)
  • Prior allergy to botulinum toxin A
  • Currently pregnant or breastfeeding

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGprabotulinumtoxinA-xvfs

Each participant will receive 60 units (U) of prabotulinumtoxinA-xvfs into each SCM for a total of 120 U. Participants will return in 2 weeks to determine if any touch-up injection is needed.


Locations(1)

The Spiegel Center

Newton, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06903975